Sandoz launches new dosages of authorized Lotrel generic
PRINCETON, N.J. — Sandoz has launched higher dosages of its authorized generic version of a hypertension drug, the generics division of Swiss drug maker Novartis said Monday.
Sandoz announced the launch of amlodipine besylate and benazepril in the 5-mg/40-mg and 10-mg/40-mg strengths. The company already marketed the drug in the 2.5-mg/10-mg, 5-mg/10-mg, 5-mg/20-mg and 10-mg/20-mg strengths.
The drug is an authorized generic of Lotrel, marketed by Novartis Pharmaceuticals. An authorized generic is a branded drug marketed under its generic name at a reduced price.
The 5-mg/40-mg and 10-mg/40-mg strengths of Lotrel had sales of around $313 million during the 12-month period ended in October 2010, according to IMS Health.